Prilova (90 mg/50 mg Hard Capsule)

Hard capsule containing prilova — prescription medication

Rx – Prescription Only
Active Ingredient
Prilova
Dosage Form
Hard capsule
Strength
90 mg/50 mg
Administration
Oral
Medically reviewed | Last reviewed: | Evidence level: 1A
Prilova is a prescription medication available as 90 mg/50 mg hard capsules. The active substance is prilova. This medication should only be used under medical supervision and according to the directions of your prescribing healthcare provider. This guide provides comprehensive information about Prilova, including how to take it, potential side effects, drug interactions, and important precautions for safe and effective use.
📅 Published:
🔄 Reviewed:
Reading time: 12 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in Clinical Pharmacology

Quick Facts About Prilova

Active Ingredient
Prilova
active substance
Available Forms
Capsule
hard capsule
Strength
90/50 mg
per capsule
Administration
Oral
by mouth
Prescription Status
Rx Only
prescription required
Brand Names
Prilova
original brand

Key Takeaways About Prilova

  • Prescription required: Prilova is a prescription-only medication and must be used under medical supervision
  • Hard capsules: Available as 90 mg/50 mg hard capsules to be swallowed whole with water
  • Follow your doctor's instructions: Always take Prilova exactly as your healthcare provider has prescribed
  • Report side effects: If you experience any unexpected symptoms while taking Prilova, contact your doctor or pharmacist promptly
  • Drug interactions: Tell your doctor about all other medications, supplements, and herbal remedies you are taking before starting Prilova

What Is Prilova and What Is It Used For?

Prilova is a prescription medication available as 90 mg/50 mg hard capsules containing the active substance prilova. It is prescribed by healthcare providers based on the patient's individual medical needs and clinical assessment.

Prilova belongs to a class of pharmaceutical agents that are used under the direction of a qualified healthcare provider. As a prescription-only medication, it has undergone rigorous evaluation by regulatory authorities such as the European Medicines Agency (EMA) and equivalent bodies worldwide to ensure its quality, safety, and efficacy before being made available to patients. The medication is formulated as a hard capsule, which is a solid oral dosage form consisting of two interlocking gelatin or hypromellose shells that enclose the active ingredient together with supporting excipients.

The active substance in Prilova is prilova, present at strengths of 90 mg and 50 mg per capsule. This fixed-dose combination formulation is designed to deliver a specific therapeutic profile that has been evaluated in clinical studies. Your doctor will determine whether Prilova is the appropriate treatment for your condition after considering your medical history, current health status, concurrent medications, and individual risk factors. It is essential that you follow the prescribed dosage and treatment duration exactly as directed by your healthcare provider.

Like all prescription medications, Prilova has been developed and tested according to strict pharmaceutical standards defined by international regulatory frameworks. The hard capsule formulation is designed for oral administration and is intended to be swallowed whole with water. The capsule shell protects the active ingredient from environmental factors such as moisture and oxygen during storage, and it dissolves in the gastrointestinal tract to release the medication for absorption.

Hard capsules offer several practical advantages over other oral dosage forms: they can accommodate varying amounts of active ingredient, they are generally easier to swallow than large tablets, and the capsule shell can mask any unpleasant taste or odour of the contents. In addition, capsules provide a convenient way to deliver combinations of active substances in a single dosage unit, supporting patient adherence to complex treatment regimens.

Important Information:

Prilova is a prescription-only medication. Do not share this medicine with others, even if they have similar symptoms. Your doctor has prescribed Prilova specifically for you based on your individual medical needs. Always use it exactly as directed by your healthcare provider, and never adjust the dose without medical advice.

What Should You Know Before Taking Prilova?

Before starting Prilova, inform your doctor about all medical conditions, allergies, and current medications. Certain conditions may require special monitoring or dose adjustments. Your healthcare provider will assess whether Prilova is suitable for you.

Contraindications

Do not take Prilova if you are allergic (hypersensitive) to prilova or any of the other ingredients in this medication. An allergic reaction may include symptoms such as skin rash, itching, hives (urticaria), swelling of the face, lips, tongue or throat, wheezing, or difficulty breathing. If you experience any of these symptoms after taking Prilova, stop taking the medication and seek immediate medical attention. Severe allergic reactions (anaphylaxis) can be life-threatening and require emergency treatment.

Your doctor will evaluate your complete medical history before prescribing Prilova to ensure there are no contraindications to its use. It is critical that you provide a complete and accurate medical history, including any previous adverse reactions to medications, known drug or food allergies, and all chronic conditions that you have been diagnosed with. Patients with severe hepatic impairment (serious liver disease) or severe renal impairment (serious kidney disease) should discuss the risks and benefits of Prilova with their healthcare provider, as dose adjustments or alternative therapies may be necessary.

If you have previously experienced an allergic reaction to any medication with a similar chemical structure or belonging to the same pharmacological class, inform your doctor before starting Prilova. Cross-reactivity between structurally related pharmaceutical compounds is possible, and your healthcare provider may recommend alternative treatments, additional monitoring, or desensitization protocols in such cases.

Warnings and Precautions

Talk to your doctor or pharmacist before taking Prilova if you have any of the following conditions or circumstances:

  • Liver disease: Patients with hepatic impairment may require dose adjustments or more frequent monitoring of liver function tests (ALT, AST, bilirubin)
  • Kidney disease: Renal impairment may affect the elimination of Prilova and its metabolites, potentially requiring dose modification based on estimated glomerular filtration rate (eGFR)
  • Cardiovascular conditions: Inform your doctor if you have heart failure, arrhythmias, previous myocardial infarction, or uncontrolled hypertension
  • Elderly patients: Older adults (typically aged 65 years and over) may be more susceptible to side effects due to age-related changes in organ function and may require lower starting doses
  • Metabolic conditions: Conditions such as diabetes, thyroid disorders, or electrolyte imbalances should be disclosed to your physician
  • Other medications: Some drugs may interact with Prilova, affecting how it works or increasing the risk of adverse effects

Regular medical check-ups may be recommended while taking Prilova to monitor your response to the medication and detect any potential adverse effects early. Your doctor may order blood tests, electrocardiograms (ECG), or other diagnostic assessments periodically to ensure that the medication is working safely and effectively. Attend all scheduled appointments and promptly report any unusual symptoms, significant changes in how you feel, or new medical problems that develop during treatment.

Before undergoing any surgical procedure, including dental surgery, inform the surgeon, anaesthesiologist, and dental professional that you are taking Prilova. Some medications need to be temporarily discontinued before certain procedures to reduce the risk of complications such as bleeding or adverse interactions with anaesthetic agents. Never stop or modify your treatment without explicit medical advice.

Pregnancy and Breastfeeding

If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before taking Prilova. The safety of Prilova during pregnancy has not been fully established in large, controlled human studies. Animal studies may have shown effects on fetal development, but the relevance to humans is not always clear. Your doctor will carefully weigh the potential benefits of treatment against the possible risks to the developing fetus before prescribing this medication during pregnancy.

It is not currently known whether prilova passes into human breast milk. Many medications are excreted in breast milk, and some can have effects on nursing infants. If you are breastfeeding or planning to breastfeed, discuss this with your doctor before starting Prilova. Your healthcare provider will help you decide whether to discontinue breastfeeding or discontinue Prilova treatment, taking into account the importance of the medication for maintaining your health and the potential impact on your nursing infant.

Women of childbearing potential should discuss effective contraceptive measures with their healthcare provider while taking Prilova, as the effects of this medication on fetal development have not been conclusively determined. If you become pregnant during treatment with Prilova, inform your doctor immediately so that appropriate clinical decisions can be made regarding continuation, modification, or discontinuation of therapy. Do not stop taking Prilova abruptly without medical guidance, as sudden discontinuation could worsen your underlying condition.

Warning – Pregnancy and Breastfeeding:

Do not start, stop, or change the dose of Prilova without consulting your healthcare provider first. If you are pregnant, planning pregnancy, or breastfeeding, your doctor will assess the individual risk-benefit ratio before making treatment decisions. Report any suspected pregnancy during treatment immediately.

Driving and Using Machines

Prilova may affect your ability to drive or operate heavy machinery in some individuals. Potential side effects such as dizziness, drowsiness, blurred vision, or fatigue could impair your reaction times and concentration. Before driving or engaging in activities that require full alertness, assess how Prilova affects you, especially during the first few days of treatment or after a dose change. If you experience any symptoms that could impair safe performance, avoid these activities and consult your doctor.

How Does Prilova Interact with Other Drugs?

Prilova may interact with other medications, potentially altering their effectiveness or increasing the risk of side effects. Always inform your doctor and pharmacist about all medicines you are currently taking, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements.

Drug interactions can occur when two or more medications are taken concurrently. These interactions may increase or decrease the effectiveness of one or both medications, or they may increase the risk of adverse effects. The clinical significance of drug interactions depends on multiple factors, including the specific medications involved, the doses used, the duration of concurrent use, individual patient characteristics, and the presence of coexisting medical conditions.

Pharmacokinetic interactions involve changes in the absorption, distribution, metabolism, or elimination of a drug. For example, some medications may affect hepatic cytochrome P450 enzymes responsible for metabolizing Prilova, leading to higher or lower blood levels of the medication than expected. Conversely, Prilova may affect the metabolism of other medications you are taking, altering their therapeutic or toxic effects. These interactions are often predictable based on the metabolic pathways of the drugs involved.

Pharmacodynamic interactions occur when two medications with similar or opposing biological effects are used together, potentially enhancing or diminishing the therapeutic or adverse effects. For instance, combining two drugs with sedative properties may cause additive central nervous system depression, while combining a drug with its antagonist may reduce its effectiveness. Your healthcare provider will carefully evaluate the potential for such interactions before prescribing Prilova in combination with other treatments.

It is also important to consider interactions with food, beverages (particularly grapefruit juice, which inhibits CYP3A4 and can dramatically alter drug levels), alcohol, and herbal products. Substances such as St. John's Wort (Hypericum perforatum) are potent enzyme inducers and can significantly reduce the plasma concentrations of many medications, potentially compromising treatment effectiveness.

Major Interactions

Known and Potential Drug Interactions
Drug / Drug Class Type of Interaction Clinical Significance Recommendation
Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, clarithromycin) Pharmacokinetic May significantly increase Prilova blood levels and risk of toxicity Avoid concomitant use when possible; dose reduction may be needed
Strong CYP3A4 inducers (e.g., rifampicin, phenytoin, carbamazepine) Pharmacokinetic May substantially decrease Prilova effectiveness Consult prescriber; alternative medication may be required
Antacids and proton pump inhibitors Absorption May reduce absorption of Prilova through gastric pH changes Take at least 2 hours apart from Prilova
Oral anticoagulants (e.g., warfarin, apixaban) Pharmacodynamic Potential increased bleeding risk Monitor INR more frequently; watch for bleeding signs
QT-prolonging medications Pharmacodynamic May increase risk of cardiac arrhythmias ECG monitoring recommended; avoid if possible
Grapefruit juice Pharmacokinetic (CYP3A4 inhibition) May increase Prilova plasma concentrations Avoid grapefruit and grapefruit juice during treatment
Herbal supplements (e.g., St. John's Wort) Pharmacokinetic May significantly reduce Prilova levels and effectiveness Avoid concurrent use; inform doctor of all supplements

Minor Interactions and Considerations

In addition to the major interactions listed above, several medications may have minor or moderate interactions with Prilova that require monitoring but may not preclude combined use. These include some antihypertensive agents, certain antidepressants, oral contraceptives, and non-steroidal anti-inflammatory drugs (NSAIDs). Your doctor will assess the clinical relevance of these interactions on an individual basis and adjust your treatment plan accordingly.

The table above is not exhaustive. Many other medications may potentially interact with Prilova. Always carry a complete list of all your medications (including over-the-counter products, dietary supplements, and herbal remedies) and share it with every healthcare provider you visit, including dentists and specialists. This practice helps prevent potentially harmful drug interactions and ensures you receive the safest and most effective treatment possible. Electronic medication records and pharmacy systems can also help identify potential interactions, but patient disclosure remains essential.

Alcohol and Prilova:

Consult your doctor about alcohol consumption while taking Prilova. Alcohol can sometimes interact with medications and may worsen certain side effects such as dizziness, drowsiness, or gastrointestinal discomfort. In some cases, alcohol may also affect the metabolism of Prilova in the liver. Your healthcare provider can advise you on whether it is safe to consume alcohol during treatment and, if so, in what quantities.

What Is the Correct Dosage of Prilova?

The standard formulation of Prilova is a 90 mg/50 mg hard capsule taken orally. Your doctor will prescribe the appropriate dose based on your individual medical needs. Always follow your doctor's instructions exactly and do not change the dose without consulting your healthcare provider.

The correct dosage of Prilova depends on several factors, including the specific condition being treated, the severity of symptoms, your age, body weight, renal function, hepatic function, concurrent medications, and individual response to treatment. Your doctor will determine the most appropriate starting dose for you and may adjust it over time based on your clinical response, laboratory results, and tolerability of the medication.

It is crucial to take Prilova exactly as prescribed and to maintain consistent timing of doses throughout your treatment. Skipping doses, taking extra doses, or abruptly discontinuing the medication without medical guidance can all negatively affect your treatment outcome. If you have questions about your dosing schedule or how to take Prilova correctly, contact your doctor or pharmacist for clarification before making any changes.

Adults

Standard Adult Dosage

The typical dose for adults is one 90 mg/50 mg hard capsule taken orally. Your doctor will specify the exact frequency of dosing (e.g., once daily, twice daily) based on your clinical needs and the pharmacokinetic profile of the medication. Swallow the capsule whole with a full glass of water. Do not open, crush, or chew the capsule unless specifically instructed by your physician, as doing so may alter the release profile and absorption of the active ingredient.

Your doctor may adjust your dose depending on how well you respond to treatment, whether you experience any side effects, and the results of any monitoring tests. Do not increase or decrease your dose, change the dosing frequency, or stop the medication without medical advice. Dose titration, when required, is typically performed gradually to minimize side effects.

Take Prilova at approximately the same time(s) each day to maintain stable plasma concentrations of the active substance. Consistent timing helps ensure optimal therapeutic effect and can also serve as a helpful reminder to take your medication regularly. Consider linking your dose to a daily routine, such as a meal or bedtime.

Children and Adolescents

Paediatric Use

The safety and efficacy of Prilova in children and adolescents under 18 years of age have not been fully established. Prilova should not be used in paediatric patients unless specifically prescribed by a specialist physician who has carefully evaluated the potential benefits and risks on an individual basis. If your doctor does prescribe Prilova for a child, follow the dosage instructions precisely and ensure that the child is closely monitored for both therapeutic response and adverse effects.

Dosing in paediatric patients, when applicable, may be based on body weight or body surface area and requires careful calculation. Because children metabolize medications differently than adults, dose adjustments and more frequent monitoring may be necessary. Do not use Prilova in children without explicit specialist guidance.

Elderly Patients

Geriatric Dosage Considerations

Elderly patients (typically aged 65 years and over) may be more sensitive to the effects of Prilova due to age-related changes in organ function, particularly reduced kidney and liver function, altered body composition, and increased susceptibility to side effects. Your doctor may prescribe a lower starting dose and increase it gradually while monitoring for adverse effects. Regular check-ups, including laboratory tests, are especially important for older adults taking Prilova.

Polypharmacy (the use of multiple medications) is common in older adults and significantly increases the risk of drug interactions. Ensure that all of your healthcare providers are aware of every medication you are taking, and consider scheduling a periodic medication review with your primary care physician or pharmacist to identify and minimize unnecessary drug combinations.

Renal and Hepatic Impairment

Dose Adjustment in Organ Impairment

Patients with renal (kidney) or hepatic (liver) impairment may require dose adjustments to prevent accumulation of the active substance and reduce the risk of toxicity. The extent of adjustment depends on the severity of impairment, typically assessed by measurements such as estimated glomerular filtration rate (eGFR) for the kidneys and Child-Pugh score for the liver. Your doctor will determine the appropriate dose based on these assessments and may also order periodic monitoring of organ function during treatment.

Missed Dose

If you forget to take a dose of Prilova, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to compensate for the one you missed, as this may increase the risk of side effects without providing additional therapeutic benefit.

If you frequently forget to take your medication, consider practical strategies to improve adherence: set alarms or reminders on your phone, use a weekly pill organizer, associate dosing with a specific daily activity (such as brushing your teeth or eating a meal), or ask a family member to help remind you. Consistent dosing is important for the medication to work effectively and maintain stable blood levels. If you have missed multiple doses in a row, contact your doctor for specific guidance on how to resume treatment safely.

Overdose

In case of overdose:

If you accidentally take more Prilova capsules than prescribed, or if someone else (particularly a child) takes your medication, contact your local poison control centre or go to the nearest emergency department immediately. Bring the medication packaging with you so that medical staff can identify the product, the strength, and the amount taken. Symptoms of overdose may include severe nausea, vomiting, dizziness, changes in heart rhythm, drowsiness, confusion, or other adverse effects that vary depending on the amount ingested and the individual's characteristics. Supportive care and close monitoring are the mainstays of overdose management.

Dosage Summary by Patient Group
Patient Group Starting Dose Notes
Adults 90 mg/50 mg (as directed) Dose and frequency determined by prescribing physician
Elderly (≥65 years) May require lower dose Adjust based on renal/hepatic function; monitor closely
Children (<18 years) Not established Use in children only under specialist supervision
Renal impairment May require adjustment Consult prescriber; monitor kidney function (eGFR)
Hepatic impairment May require adjustment Consult prescriber; monitor liver function (LFTs)

What Are the Side Effects of Prilova?

Like all medicines, Prilova can cause side effects, although not everybody gets them. Most side effects are mild to moderate and temporary. Contact your doctor immediately if you experience any severe, persistent, or unexpected symptoms.

Side effects are unwanted reactions that may occur when taking a medication. They are usually classified by frequency according to the Council for International Organizations of Medical Sciences (CIOMS) system: very common (affects more than 1 in 10 people), common (affects 1 in 10 to 1 in 100 people), uncommon (affects 1 in 100 to 1 in 1,000 people), rare (affects 1 in 1,000 to 1 in 10,000 people), and very rare (affects fewer than 1 in 10,000 people). The severity, type, and duration of side effects can vary significantly from person to person.

It is important to distinguish between dose-related side effects and allergic reactions. While most side effects are predictable, dose-dependent, and resolve upon dose reduction or discontinuation, allergic reactions are unpredictable immune-mediated responses that can occur at any dose, even on first exposure. Signs of a serious allergic reaction (anaphylaxis) include difficulty breathing, swelling of the face, lips, tongue, or throat, severe skin rash with blistering, rapid heartbeat, or dizziness leading to collapse. If you experience any of these symptoms, seek emergency medical attention immediately by calling your local emergency number.

Many side effects improve as your body adjusts to the medication over the first few weeks of treatment. However, if any side effect persists, worsens, or causes significant discomfort or impairment of daily functioning, contact your healthcare provider. Your doctor may adjust your dose, recommend supportive measures to manage the side effect, or consider alternative treatment options. Never stop taking Prilova abruptly without medical advice, even if you experience side effects.

Common Side Effects

May affect up to 1 in 10 people

  • Headache
  • Nausea
  • Dizziness or light-headedness
  • Fatigue or general tiredness
  • Gastrointestinal discomfort (stomach pain, bloating)
  • Loss of appetite

Uncommon Side Effects

May affect up to 1 in 100 people

  • Skin rash or itching (pruritus)
  • Diarrhoea or constipation
  • Dry mouth (xerostomia)
  • Insomnia or sleep disturbances
  • Muscle or joint pain (myalgia, arthralgia)
  • Changes in appetite or weight
  • Vomiting
  • Heartburn or dyspepsia

Rare Side Effects

May affect up to 1 in 1,000 people

  • Elevated liver enzymes (ALT, AST)
  • Changes in blood cell counts (anaemia, leukopenia)
  • Mood changes, anxiety, or depression
  • Visual disturbances or blurred vision
  • Palpitations or irregular heartbeat
  • Peripheral oedema (swelling of hands or feet)

Serious Reactions Requiring Immediate Attention

Seek emergency care

  • Severe allergic reaction (anaphylaxis)
  • Angioedema (swelling of face, lips, tongue, or throat)
  • Severe skin reactions (e.g., Stevens-Johnson syndrome)
  • Signs of liver injury (jaundice, dark urine)
  • Severe cardiovascular symptoms (chest pain, fainting)
Seek immediate medical attention if you experience:

Signs of a serious allergic reaction such as swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe skin rash with blistering or peeling; rapid heartbeat; chest pain; yellowing of the skin or eyes (jaundice); or feeling faint. These symptoms require emergency medical care. Stop taking Prilova and call your local emergency number or go to the nearest emergency department immediately.

You are strongly encouraged to report any suspected side effects to your healthcare provider or to your national pharmacovigilance authority. In Europe, suspected adverse drug reactions can be reported through national reporting schemes coordinated by the European Medicines Agency (EMA). In the United States, adverse events can be reported to the FDA MedWatch programme. Reporting side effects helps regulatory agencies and pharmaceutical companies identify previously unknown adverse reactions, assess the overall safety profile of medications, and improve the safety information available for all patients.

How Should You Store Prilova?

Store Prilova at room temperature below 25°C (77°F) in the original packaging. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.

Proper storage of medications is essential to maintain their quality, safety, and effectiveness over their intended shelf life. Prilova hard capsules should be stored in a cool, dry place at a temperature not exceeding 25°C (77°F). Avoid exposing the medication to excessive heat (e.g., direct sunlight, near heating appliances), direct sunlight, or high humidity, as these conditions can degrade the active ingredient and compromise the effectiveness of the capsules.

Keep the capsules in their original packaging until you are ready to take them. The original packaging (blister packs or bottles) is specifically designed to protect the medication from environmental factors such as light, oxygen, and moisture. If your medication is supplied in blister packs, do not remove a capsule from the blister until immediately before use. If the capsules are supplied in a bottle, keep the bottle tightly closed when not in use, and do not remove the desiccant (if present), as it helps absorb moisture within the container.

The bathroom is not an ideal storage location for most medications because of fluctuations in temperature and humidity caused by showers and baths. Instead, choose a cool, dry cabinet or drawer away from heat sources and out of direct sunlight. Medication storage boxes or a designated kitchen cabinet (away from the stove) are often good options, provided they can be secured out of reach of children.

Always keep Prilova and all medications out of the reach and sight of children. Store medications in a locked cabinet or a location that children cannot access. Child-resistant packaging reduces but does not eliminate the risk of accidental ingestion. Accidental ingestion of prescription medications by children is a medical emergency and requires immediate attention from poison control or an emergency department, even if the child appears to be unaffected initially.

Do not use Prilova after the expiry date stated on the packaging. The expiry date refers to the last day of that month (e.g., an expiry date of "05/2027" means the medication is usable through 31 May 2027). Expired medications may have reduced effectiveness, altered chemical composition, and in some cases could potentially be harmful. Check the expiry date regularly and return any unused or expired capsules to your pharmacist for safe disposal.

Proper disposal of unused medication:

Do not dispose of Prilova via wastewater (flushing down the toilet or sink) or household waste (general rubbish bin). These disposal methods can contribute to environmental contamination and pose a risk to wildlife and water supplies. Return any unused capsules to your pharmacy for safe disposal. Many pharmacies and healthcare facilities offer medication take-back programmes. In some countries, specific schemes exist for incinerating returned medications at controlled high-temperature facilities, which is the preferred method for protecting the environment and preventing accidental exposure or misuse.

What Does Prilova Contain?

Each Prilova hard capsule contains prilova as the active substance (at the 90 mg/50 mg strength), along with pharmaceutical excipients that support the capsule's structure, stability, and performance in the gastrointestinal tract.

The active ingredient in each hard capsule is prilova, present at the labelled strength of 90 mg/50 mg. This is the substance responsible for the therapeutic effect of the medication. The amount of active ingredient has been carefully determined through preclinical and clinical research to provide the desired pharmacological effect while maintaining an acceptable safety profile. The combination formulation is designed to deliver both components in a consistent ratio with a single dose, supporting treatment adherence.

In addition to the active ingredient, Prilova capsules contain inactive ingredients (excipients) that serve various essential pharmaceutical functions. These excipients typically include diluents or fillers that provide bulk, disintegrants that help the capsule contents break apart in the gastrointestinal tract, lubricants that prevent sticking during manufacturing, flow aids that facilitate uniform filling of the capsules, and the capsule shell components themselves. Common excipients found in hard capsules include microcrystalline cellulose, lactose monohydrate, magnesium stearate, colloidal silicon dioxide, and starches.

The hard capsule shell is typically composed of gelatin (animal-derived) or hypromellose (plant-derived, suitable for vegetarian or vegan patients), along with colouring agents such as titanium dioxide (white pigment) and iron oxides (for coloured capsules). The shell may also contain small amounts of water and, in some formulations, preservatives or plasticizers. Capsule shells are designed to dissolve rapidly in the stomach or upper small intestine, releasing the contents for absorption.

If you have known allergies or intolerances to any pharmaceutical excipients, such as lactose intolerance or hypersensitivity to certain dyes, discuss this with your doctor or pharmacist before starting Prilova. They can verify whether the specific excipients in your formulation are compatible with your dietary restrictions and allergies. Patients with galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take medicinal products containing lactose without medical advice. Vegetarians, vegans, and patients following religious dietary restrictions should confirm the composition of the capsule shell before starting treatment.

The complete list of excipients, together with information about the capsule's appearance (size, colour, imprint) and pack sizes, is available in the patient information leaflet (PIL) included in the medication packaging. The summary of product characteristics (SmPC), intended for healthcare professionals, contains additional detailed information about the formulation. If you require further information about the composition of Prilova, contact the manufacturer through the details provided on the packaging or consult your pharmacist.

Frequently Asked Questions About Prilova

Prilova is a prescription medication available as 90 mg/50 mg hard capsules containing the active substance prilova. Your doctor will prescribe Prilova based on your specific medical condition and clinical needs. The medication requires a prescription because it must be used under appropriate medical supervision, with proper assessment of suitability, dose selection, and monitoring of response. Always follow your healthcare provider's instructions regarding the purpose, dosage, timing, and duration of treatment with Prilova. Do not use this medication for conditions other than those for which it was prescribed.

Take Prilova exactly as your doctor has instructed. Swallow the hard capsule whole with a full glass of water. Do not open, crush, or chew the capsule unless specifically told to do so by your doctor, as this may affect how the active substance is released and absorbed. Your healthcare provider will tell you how many capsules to take and how often. Take the medication at approximately the same time(s) each day to help you remember and to maintain consistent blood levels of the medication. If your doctor recommends taking Prilova with or without food, follow those instructions carefully.

If you miss a dose of Prilova, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never take a double dose to make up for a forgotten dose, as this may increase the risk of side effects. If you are unsure about what to do after missing a dose, contact your doctor or pharmacist for guidance. Consider using a pill organizer, setting phone reminders, or linking your dose to a daily habit (such as meals or bedtime) to help you remember to take your medication consistently.

You should consult your doctor about alcohol consumption while taking Prilova. Alcohol can sometimes interact with medications and may increase the risk of certain side effects, such as dizziness, drowsiness, or gastrointestinal problems. Alcohol may also affect the liver's ability to metabolize medications, potentially altering how Prilova works in your body. Your healthcare provider can give you personalized advice based on your specific medical situation, the dose and frequency of Prilova you are taking, and other medications you may be using concurrently. In general, moderation is advisable, and avoidance may be recommended in some cases.

No, Prilova is classified as a prescription-only medication (Rx). This means you need a valid prescription from a licensed healthcare provider, such as a physician or qualified nurse prescriber, to obtain it from a pharmacy. The prescription requirement ensures that the medication is used under appropriate medical supervision, with proper assessment of the indication, monitoring of its effects, and identification of potential side effects or interactions. Do not attempt to obtain or use Prilova without a valid prescription, and do not share your prescribed medication with others.

Store Prilova at room temperature below 25°C (77°F) in the original packaging to protect the capsules from moisture and light. Keep the medication out of reach and sight of children, preferably in a locked cabinet. Do not use Prilova after the expiry date printed on the carton or blister pack. The expiry date refers to the last day of that month. Do not dispose of medications via wastewater (toilet or sink) or household waste – return any unused or expired capsules to your pharmacist for safe disposal through medication take-back programmes.

Do not stop taking Prilova without consulting your doctor, even if you feel better. Many medications are intended to be taken for a specific duration or as a long-term therapy, and stopping treatment prematurely can lead to the return or worsening of your original condition. In some cases, abrupt discontinuation of medications can cause withdrawal symptoms or rebound effects. If you feel that Prilova is no longer needed, or if you are experiencing troublesome side effects, discuss this with your healthcare provider. Your doctor may gradually reduce your dose (taper) before stopping the medication completely, if appropriate.

References and Sources

This article is based on internationally recognized medical and pharmaceutical guidelines. All information has been reviewed by qualified healthcare professionals and follows evidence-based principles in accordance with the GRADE framework.

  1. European Medicines Agency (EMA). Guideline on Summary of Product Characteristics (SmPC). EMA, 2024. Available at: www.ema.europa.eu
  2. World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List, 2023. Geneva: World Health Organization, 2023. Available at: www.who.int
  3. British National Formulary (BNF). Prescribing Guidance: Drug Interactions and Side Effects. NICE, 2024. Available at: bnf.nice.org.uk
  4. U.S. Food and Drug Administration (FDA). Drug Safety Communications and Labeling Changes. FDA, 2024. Available at: www.fda.gov
  5. Goodman & Gilman's. The Pharmacological Basis of Therapeutics. 14th Edition. McGraw-Hill Education, 2023.
  6. European Pharmacopoeia Commission. European Pharmacopoeia, 11th Edition. Council of Europe, 2023.
  7. International Council for Harmonisation (ICH). ICH E2C(R2): Periodic Benefit-Risk Evaluation Report. ICH, 2023.
  8. Council for International Organizations of Medical Sciences (CIOMS). Guidelines for Preparing Core Clinical-Safety Information on Drugs. CIOMS, 2022.
  9. Stockley's Drug Interactions. A Source Book of Interactions, Their Mechanisms, Clinical Importance, and Management. 13th Edition. Pharmaceutical Press, 2023.

About the Medical Editorial Team

This article has been written and reviewed by iMedic's Medical Editorial Team, consisting of licensed physicians and specialists in clinical pharmacology with expertise in drug safety, pharmacovigilance, and evidence-based medicine.

Medical Writing

iMedic Medical Editorial Team – specialists in clinical pharmacology and drug information. All content is researched and written using peer-reviewed sources, regulatory documents, and international pharmaceutical guidelines.

Medical Review

iMedic Medical Review Board – independent panel of qualified physicians who review all drug information content for accuracy, completeness, and clinical relevance according to EMA, FDA, and WHO standards.

Editorial Standards: All pharmaceutical content on iMedic follows strict editorial standards based on the GRADE evidence framework. We do not accept any form of pharmaceutical industry sponsorship or advertising. Our content is independent, evidence-based, and written for patients and caregivers. Read more about our editorial standards.